0001567619-18-002329.txt : 20180907 0001567619-18-002329.hdr.sgml : 20180907 20180907193457 ACCESSION NUMBER: 0001567619-18-002329 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180905 FILED AS OF DATE: 20180907 DATE AS OF CHANGE: 20180907 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALVAREZ EDUARDO CENTRAL INDEX KEY: 0001720126 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34885 FILM NUMBER: 181061135 MAIL ADDRESS: STREET 1: AMYRIS, INC. STREET 2: 5885 HOLLIS STREET, SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMYRIS, INC. CENTRAL INDEX KEY: 0001365916 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 550856151 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5885 HOLLIS STREET, SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-450-0761 MAIL ADDRESS: STREET 1: 5885 HOLLIS STREET, SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: AMYRIS BIOTECHNOLOGIES INC DATE OF NAME CHANGE: 20060613 4 1 doc1.xml FORM 4 X0306 4 2018-09-05 0 0001365916 AMYRIS, INC. AMRS 0001720126 ALVAREZ EDUARDO C/O AMYRIS, INC. 5885 HOLLIS STREET, SUITE 100 EMERYVILLE CA 94608 0 1 0 0 Chief Operating Officer Common Stock 2018-09-05 4 P 0 11877 8.4471 A 331877 D The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.42 to $8.45 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). /s/ Eduardo Alvarez by Stephen Dobson, Attorney-in-Fact 2018-09-07